首页> 外文期刊>Journal of cardiothoracic and vascular anesthesia >Outcome in patients who require venoarterial extracorporeal membrane oxygenation support after cardiac surgery.
【24h】

Outcome in patients who require venoarterial extracorporeal membrane oxygenation support after cardiac surgery.

机译:心脏手术后需要静脉动脉体外膜氧合支持的患者的结果。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: The authors analyzed hospital mortality in adult cardiac surgery patients who required postoperative venoarterial extracorporeal membrane oxygenation (ECMO) support for circulatory failure and identified perioperative patient variables associated with hospital mortality in these patients. DESIGN: A retrospective study. SETTING: A single institution, tertiary academic center. PARTICIPANTS: Adult patients requiring venoarterial ECMO support after cardiac surgery from January 1995 to December 2005 were identified from the Anesthesiology Institute Patient Registry. Twenty-two preselected patient variables were entered into a logistic regression model of hospital death. INTERVENTIONS: None. RESULTS: Two hundred thirty-three of 40,116 (0.58%) adult cardiac surgery patients required postoperative venoarterial ECMO, and among these, 149 (64%) died in the hospital. In an unadjusted analysis, older age, higher preoperative albumin, diabetes history, coronary artery bypass graft surgery, and longer total cardiopulmonary bypass (CPB) time were associated with increased hospital mortality, and a history of cardiogenic shock was associated with decreased mortality. In an adjusted logistic regression analysis, a history of cardiogenic shock and younger age were associated with decreased hospital mortality. The overall use of postoperative venoarterial ECMO in this patient population decreased since its peak in 1996. CONCLUSION: Venoarterial ECMO support after cardiac surgery was required in a small fraction of patients and was associated with very high hospital mortality; but among those requiring ECMO, mortality in these patients was lower in younger, nondiabetic patients with cardiogenic shock who had shorter CPB times. The mortality associated patient variables identified are not easily modifiable and do not appear sufficiently robust to define which patients should be selected for this potentially life-saving therapy.
机译:目的:作者分析了需要心脏静脉术后体外膜氧合(ECMO)支持以维持循环衰竭的成年心脏手术患者的医院死亡率,并确定了与这些患者住院死亡率相关的围手术期患者变量。设计:一项回顾性研究。地点:单一机构,大专学术中心。参与者:1995年1月至2005年12月在心脏手术后需要静脉大动脉ECMO支持的成年患者是从麻醉学研究所患者登记处确定的。将22个预先选择的患者变量输入到医院死亡的逻辑回归模型中。干预措施:无。结果:40,116名成人心脏外科手术患者中有233例需要术后静脉性ECMO,其中149例(64%)在医院死亡。在未经调整的分析中,年龄较大,术前白蛋白升高,糖尿病史,冠状动脉搭桥术和更长的总体外循环时间(CPB)与医院死亡率增加有关,而心源性休克病史与死亡率降低有关。在调整后的logistic回归分析中,心源性休克病史和年龄较小与医院死亡率降低相关。自1996年达到峰值以来,该患者术后静脉动静脉ECMO的总体使用率下降。结论:心脏外科手术后的静脉动静脉ECMO支持在一小部分患者中是必需的,并且与很高的医院死亡率相关;但在需要ECMO的患者中,这些患者的死亡率在CPB时间较短的年轻,非糖尿病性心源性休克患者中较低。所确定的与死亡率相关的患者变量不容易修改,并且似乎不足以确定应选择哪些患者进行这种可能挽救生命的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号